$35 million gift from Richard K. and Nancy K. Lubin to support the future of cancer care
Richard K. and Nancy K. Lubin have made a $35 million gift to Dana-Farber Cancer Institute’s Future of Cancer Care Fund, which provides resources to the areas of greatest need at Dana-Farber, including the Lavine Bekenstein Cancer Hospital.
This generous gift will support cancer research, early detection, survivorship, patient assistance and psychosocial services, as well as construction of the Lavine Bekenstein Cancer Hospital at Dana-Farber, a 300-bed inpatient hospital being constructed on the former site of the Joslin Diabetes Center along Brookline Avenue.
In recognition of their extraordinary gift, the third floor of the Lavine Bekenstein Cancer Hospital will be named in their honor. For Richard and Nancy, this gift represents both a continuation of their longstanding commitment to
“We are tremendously grateful for the generous gift from Richard and Nancy Lubin,” said Benjamin L. Ebert, MD, PhD, president and CEO of Dana-Farber Cancer Institute.
“This gift exemplifies the Lubin family’s deep and enduring commitment to Dana-Farber and to nurturing the next generation of physician-scientists. Their support is transforming cancer research and care and ensuring a brighter future for patients and their families.”
As a Trustee since the early 1990s, Richard has been instrumental in Dana-Farber’s evolution and how it has grown and adapted to meet the needs not only of patients, but those around the world who benefit from research
The combination of innovative clinical research and compassionate care for each patient has always been at the forefront of the mission and remains among the factors that are
“In terms of taking care of patients and finding cures and new treatments for cancer, there’s no place we can think of in the world that’s as important as Dana-Farber,” said Richard and Nancy Lubin.
“It was easy for us to determine that anything we could do to help make the future cancer hospital endeavor come to fruition was incredibly important.”
“Richard and Nancy’s gift will allow Dana-Farber to provide world-class care, while also funding groundbreaking discoveries and treatments,” said Dana-Farber board chair Josh Bekenstein.
“Providing a facility that fosters the intersection of clinical care and research in real-time will further cement Dana-Farber’s position as the trailblazing leader in cancer care.”
Designed as a clinical and physical crossroads, the third floor will be an important hub for patients, families, faculty, and staff. In addition to housing essential services such as imaging, observation, and pharmacy, the third floor will create seamless connections across the Longwood Medical Area, with two bridges connecting to the floor.
The Jean and Tom Yawkey Bridge across Brookline Avenue will connect patients and staff with Dana-Farber’s Yawkey Center for Cancer Care, and a connector across Pilgrim Road will provide access to Beth Israel Deaconess Medical Center facilities.
Over nearly four decades, the Lubin family and Richard K. Lubin Family Foundation have been staunch supporters of research, facilities and infrastructure, and the development of early career physician-scientists at Dana-Farber.
Their philanthropy has aided Dana-Farber’s efforts in drug development and cancer chemical biology for skin cancer; construction of the Yawkey Center for Cancer Care, which includes the Richard and Nancy Lubin Lobby on the building’s second floor; the Richard and Nancy Lubin Family Chair at Dana-Farber; and, since 2022, the Lubin Family Foundation Scholar Award, a signature program dedicated to advancing the careers of promising early career investigators.